by Christina Babu | Jul 27, 2023 | Press Release
EmVenio Research today announced a partnership with TrialHub, a data intelligence platform that delivers real-time patient insights and empowers EmVenio to conduct a wider range of clinical trials for new life-saving treatments. Through TrialHub’s data intelligence...
by EmVenio | Jun 20, 2023 | Press Release
U.S.-based researcher and EMS Healthcare collaborate to conduct commercial clinical trials through a network of mobile research sites. DURHAM, N.C., June 20, 2023 – Community research provider EmVenio Research today announced its international expansion with the...
by EmVenio | Jun 1, 2023 | Press Release
Esteemed pharmaceutical leader Dr. Neil Kurtz appointed to board chair DURHAM, N.C., June 1, 2023 – Clinical trial organization EmVenio Research today announced the inception of an advisory board of veteran industry leaders. The board will provide strategic oversight...
by EmVenio | May 18, 2023 | Press Release
DURHAM, N.C., May 18, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Chicago, Illinois, on the Illinois Medical District campus as part of a concerted effort to maximize diversity, equity and inclusion in research studies and...
by EmVenio | May 17, 2023 | Press Release
Durham, NC – May 17, 2023 – EmVenio Research, a company providing rapid and scalable mobile research sites in order to better reach and recruit diverse, underserved and high-risk communities, has partnered with Socially Determined, a social risk analytics...
by EmVenio | Apr 11, 2023 | Press Release
DURHAM, N.C., April 11, 2023 /PRNewswire/ — EmVenio Research today announced the appointment of Dr. Mark McKenzie, M.D. as its chief medical officer. In this role, Dr. McKenzie will lead and strategize new initiatives in the clinical and...
